Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pediatr.

Sec. Pediatric Neurology

Volume 13 - 2025 | doi: 10.3389/fped.2025.1681103

This article is part of the Research TopicAdvancing Rett Syndrome Research: Insights into MECP2 Function and Therapeutic ApproachesView all articles

Predictors of Aspiration, Lower Respiratory Tract Infection, and Respiratory Failure among Individuals with Rett Syndrome: Analysis of Real-World Claims Data in the United States

Provisionally accepted
Krithika  RajagopalanKrithika Rajagopalan1*Nazia  RashidNazia Rashid2Dilesh  DoshiDilesh Doshi2Daksha  GopalDaksha Gopal1
  • 1Anlitiks Inc, Windermere, United States
  • 2Acadia Pharmaceuticals Inc, San Diego, United States

The final, formatted version of the article will be published soon.

Background: Rett (RTT) syndrome, a rare, neurodevelopmental disorder affects multiple organ-systems (i.e., gastrointestinal, respiratory,) with diverse clinical manifestations. While gastrointestinal manifestations are well-known, respiratory manifestations [i.e., aspiration, lower respiratory tract infection (LRTI), and respiratory failure (RF)] and associated predictors are not well-studied. This real-world data analysis evaluated the predictors of aspiration, LRTI, and RF among RTT individuals in the United States. Methods: A retrospective database analysis using IQVIA's Anonymized Patient Level database from 08/01/2020 to 03/31/2023 was conducted to identify newly diagnosed RTT individuals with ≥1 RTT diagnostic claim (ICD-10-CM: F84.2) between 02/01/2021 to 03/31/2022. Index date was the first RTT diagnostic claim. Eligible sample included individuals with 6-months pre-index and 12-months post-index follow-up, as well as no pre-index cerebrovascular disease or brain trauma diagnosis. Predictors of aspiration, LRTI, and RF were separately evaluated using exploratory backward selection models followed by confirmatory multivariable logistic regressions and reported using odds ratios (OR) with 95% confidence intervals (95% CI). Results: Of the 1,994 with RTT, 7.27% (n=145), 9.48% (n=189), and 10.08% (n=201) experienced post-index aspiration, LRTI, and RF, respectively. Significant predictors for aspiration were cough [3.39 (1.82–6.29)], dysphagia [3.04 (1.86–4.99)], LRTI [2.34 (1.22–4.51)], and neurological disorders (i.e., epilepsy/convulsions) [1.77 (1.18–2.66)]; LRTI were respiratory disorders [4.06 (2.63–6.27)], RF [3.02 (1.65–5.53)], neurological disorders [1.57 (1.07–2.29)], and gastrointestinal disorders [1.57 (1.04–2.37)]; RF were LRTI [4.70 (2.58–8.58)], respiratory disorders [3.38 (2.23–5.13)], dysphagia [2.73 (1.73–4.31)], gastrointestinal disorders [2.09 (1.40–3.10)], musculoskeletal disorders [1.86 (1.01–3.40)], and neurological disorders [1.69 (1.16–2.45)]. Conclusion: Baseline neurological and respiratory disorders were common predictors of aspiration, LRTI, or RF. Additional predictors included gastrointestinal disorders for LRTI and RF; and musculoskeletal disorders for RF only. These real-world findings can help inform evidence based clinical decision-making for management of RTT.

Keywords: Rett Syndrome, predictors, aspiration, Respiratory outcomes, Cough, Lower respiratory tract infection, respiratory failure

Received: 06 Aug 2025; Accepted: 12 Sep 2025.

Copyright: © 2025 Rajagopalan, Rashid, Doshi and Gopal. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Krithika Rajagopalan, kr.rajagopalan@anlitiks.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.